Company intelligence / Profile preview

Oxy Solutions

Oslo, Norway

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Oxy Solutions has developed and patented a proprietary nanobubble oxygenation platform for highly oxygenating liquids. Their technology is commercially deployed, with demonstrated applications in aquaculture and wound healing. Wound care applications include an oxygenated wound gel with clinical utility, while the aquaculture solution has been validated for stable, high-level oxygenation improving health and growth rates in fish farming.

Therapeutic areas: Dermatology
Modalities: DeviceNanobubble oxygenation platform
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Oxy Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxy Solutions.

Explore the full profile